Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
HFM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
THOC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC44A5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FGF18 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATRX - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PGAP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FABP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EIF2S1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRIM24 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ANXA4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCDHB9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
STXBP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101928160 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PARVB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EPS15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SCRN3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FBXO17 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GPR160 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on